Feroz Osmani, MD
Interventional Pain Medicine · Georgetown, TXNPI 1780180190
Payments from drug & device makers
What this record shows
This record is dominated by grants: $20,000 of the $31,588 with a category attached, or 63.3%. Boston Scientific accounts for 66.6% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $20,180 and has fallen 83.6% since, to $3,318 in 2025.
Across 177 payments — averaging $178.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$21K
- Abbott$6K
- Medtronic$2K
- Nevro Corp.$608
- Nalu Medical, Inc.$328
- Saluda Medical Americas, Inc.$323
- plus $1K from 15 others
What the payments were for
- Consulting fees$1250%
- Grants$20,00063%
- Travel & lodging$2,7759%
- Food & beverage$8,68928%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $21,041 |
| Abbott | 66 | $6,265 |
| Medtronic | 33 | $1,538 |
| Nevro Corp. | 9 | $608 |
| Nalu Medical, Inc. | 4 | $328 |
| Saluda Medical Americas, Inc. | 2 | $323 |
| SPR Therapeutics, Inc | 4 | $262 |
| Collegium Pharmaceutical, Inc. | 14 | $251 |
| Globus Medical | 5 | $200 |
| AbbVie | 7 | $150 |
| Zynex Medical, Inc. | 1 | $140 |
| Pfizer | 8 | $133 |
| Si-bone, Inc. | 3 | $102 |
| Stryker | 2 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $45 |
| Averitas Pharma Inc. | 2 | $38 |
| Vertos Medical, Inc. | 1 | $33 |
| Vertex | 1 | $22 |
| Curonix LLC | 1 | $21 |
| IBSA Pharma Inc. | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WaveWriter Alpha Prime 16$20,000
- PROCLAIM$3,636
- OCTRODE$928
- Superion Indirect Decompression System$732
- Senza$440
- INTELLIS ADAPTIVESTIM$317
- Nalu Neurostimulation System$247
- Evoke SCS$206
- INCEPTIV$171
- Nexwave$140
- SPRINT PNS System$126
- Evoke$117
- OSTEOCOOL RF ABLATION SYSTEM$109
How this compares
$31,588 in reported general payments places this provider in the 85th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 442 | $12,305 |
| Xtampza ErOxycodone Myristate | 22 | $10,591 |
| OxycontinOxycodone Hcl | 13 | $6,060 |
| Buprenorphine | 23 | $4,351 |
| Morphine Sulfate ErMorphine Sulfate | 62 | $2,846 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 99 | $2,527 |
| Oxycodone Hcl | 73 | $1,335 |
| Tramadol Hcl ErTramadol Hcl | 18 | $1,301 |
| Lidocaine | 21 | $1,262 |
| Duloxetine Hcl | 96 | $815 |
| Pregabalin | 80 | $711 |
| Gabapentin | 63 | $684 |
| Cyclobenzaprine Hcl | 67 | $632 |
| Tizanidine Hcl | 73 | $604 |
| Tramadol Hcl | 78 | $560 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $251 | $10,59122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 287 interventional pain medicine providers in Texas.
Other interventional pain medicine in Georgetown
- Allen DennisGeorgetown$52K
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.1M
- Chad StephensSouthlake$1M
- Ankur KhoslaShenandoah$277K
- Brian RichDecatur$245K
- Brian BruelHouston$219K
- Bolkar SahinlerLubbock$188K
- Timothy RatinoFort Worth$139K
- Genaro GutierrezAustin$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.